// App-Quantinova.ai

e21227 : Experience of nivolumab and pembrolizumab in metastatic non-small cell lung cancer in routine clinical practice (mNSCLC.).

Researchers

Presenter

  • Doran Ksienski

Principal Investigators

  • Edward Geoffrey Brooks

  • Dave Fenton

  • Leathia Fiorino

  • Georgia Samantha Geller

  • Zia Poonja

  • Daniel Glick

Medical Centers

  • British Columbia Cancer Agency, Vancouver, BC, Canada

  • Cross Cancer Institute, Edmonton, AB, Canada

  • BCCA, Vancouver, BC, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Pembrolizumab

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved